Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia
Roboz, Gail J., DiNardo, Courtney D., Stein, Eytan M., de Botton, Stéphane, Mims, Alice S., Prince, Gabrielle T., Altman, Jessica K., Arellano, Martha L., Donnellan, Will, Erba, Harry P., Mannis, Gabriel N., Pollyea, Daniel A., Stein, Anthony S., Uy, Geoffrey L., Watts, Justin M., Fathi, Amir T., Kantarjian, Hagop M., Tallman, Martin S., Choe, Sung, Dai, David, Fan, Bin, Wang, Hongfang, Zhang, Vickie, Yen, Katharine E., Kapsalis, Stephanie M., Hickman, Denice, Liu, Hua, Agresta, Samuel V., Wu, Bin, Attar, Eyal C., Stone, Richard M.
Published in Blood (13.02.2020)
Published in Blood (13.02.2020)
Get full text
Journal Article
Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia
Pollyea, Daniel A, Tallman, Martin S, de Botton, Stéphane, Kantarjian, Hagop M, Collins, Robert, Stein, Anthony S, Frattini, Mark G, Xu, Qiang, Tosolini, Alessandra, See, Wendy L, MacBeth, Kyle J, Agresta, Samuel V, Attar, Eyal C, DiNardo, Courtney D, Stein, Eytan M
Published in Leukemia (01.11.2019)
Published in Leukemia (01.11.2019)
Get full text
Journal Article
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study
Lowery, Maeve A, Burris, 3rd, Howard A, Janku, Filip, Shroff, Rachna T, Cleary, James M, Azad, Nilofer S, Goyal, Lipika, Maher, Elizabeth A, Gore, Lia, Hollebecque, Antoine, Beeram, Muralidhar, Trent, Jonathan C, Jiang, Liewen, Fan, Bin, Aguado-Fraile, Elia, Choe, Sung, Wu, Bin, Gliser, Camelia, Agresta, Samuel V, Pandya, Shuchi S, Zhu, Andrew X, Abou-Alfa, Ghassan K
Published in The lancet. Gastroenterology & hepatology (01.09.2019)
Published in The lancet. Gastroenterology & hepatology (01.09.2019)
Get more information
Journal Article
Clinical pharmacokinetics and pharmacodynamics of ivosidenib in patients with advanced hematologic malignancies with an IDH1 mutation
Fan, Bin, Dai, David, DiNardo, Courtney D., Stein, Eytan, de Botton, Stéphane, Attar, Eyal C., Liu, Hua, Liu, Guowen, Lemieux, Ian, Agresta, Samuel V., Yang, Hua
Published in Cancer chemotherapy and pharmacology (01.05.2020)
Published in Cancer chemotherapy and pharmacology (01.05.2020)
Get full text
Journal Article
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia
DiNardo, Courtney D., Propert, Kathleen J., Loren, Alison W., Paietta, Elisabeth, Sun, Zhuoxin, Levine, Ross L., Straley, Kimberly S., Yen, Katharine, Patel, Jay P., Agresta, Samuel, Abdel-Wahab, Omar, Perl, Alexander E., Litzow, Mark R., Rowe, Jacob M., Lazarus, Hillard M., Fernandez, Hugo F., Margolis, David J., Tallman, Martin S., Luger, Selina M., Carroll, Martin
Published in Blood (13.06.2013)
Published in Blood (13.06.2013)
Get full text
Journal Article
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response
Fathi, Amir T., Sadrzadeh, Hossein, Borger, Darrell R., Ballen, Karen K., Amrein, Philip C., Attar, Eyal C., Foster, Julia, Burke, Meghan, Lopez, Hector U., Matulis, Christina R., Edmonds, Katherine M., Iafrate, A. John, Straley, Kimberly S., Yen, Katharine E., Agresta, Samuel, Schenkein, David P., Hill, Cedric, Emadi, Ashkan, Neuberg, Donna S., Stone, Richard M., Chen, Yi-Bin
Published in Blood (29.11.2012)
Published in Blood (29.11.2012)
Get full text
Journal Article
HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
Reynolds, Joseph G., Geretti, Elena, Hendriks, Bart S., Lee, Helen, Leonard, Shannon C., Klinz, Stephan G., Noble, Charles O., Lücker, Petra B., Zandstra, Peter W., Drummond, Daryl C., Olivier, Kenneth J., Nielsen, Ulrik B., Niyikiza, Clet, Agresta, Samuel V., Wickham, Thomas J.
Published in Toxicology and applied pharmacology (01.07.2012)
Published in Toxicology and applied pharmacology (01.07.2012)
Get full text
Journal Article
Rhabdomyosarcoma of the maxillary gingiva
Chi, Angela C, Barnes, Jeffrey D, Budnick, Steven, Agresta, Samuel V, Neville, Brad
Published in Journal of periodontology (1970) (01.09.2007)
Published in Journal of periodontology (1970) (01.09.2007)
Get more information
Journal Article
Practical issues of intraoperative frozen section diagnosis of bone and soft tissue lesions
Bui, Marilyn M, Smith, Prudence, Agresta, Samuel V, Cheong, David, Letson, G Douglas
Published in Cancer control (01.01.2008)
Published in Cancer control (01.01.2008)
Get full text
Journal Article
Therapeutic potential of directed tyrosine kinase inhibitor therapy in sarcomas
Shor, Audrey C, Agresta, Samuel V, D'Amato, Gina Z, Sondak, Vernon K
Published in Cancer control (01.01.2008)
Published in Cancer control (01.01.2008)
Get full text
Journal Article
Phase I study of AG-120, an IDH1 mutant enzyme inhibitor: Results from the cholangiocarcinoma dose escalation and expansion cohorts
Lowery, Maeve Aine, Abou-Alfa, Ghassan K., Burris, Howard A., Janku, Filip, Shroff, Rachna T., Cleary, James M., Azad, Nilofer Saba, Goyal, Lipika, Maher, Elizabeth A., Gore, Lia, Hollebecque, Antoine, Beeram, Muralidhar, Trent, Jonathan C., Jiang, Liewen, Ishii, Yuko, Auer, Julia, Gliser, Camelia, Agresta, Samuel V., Pandya, Shuchi Sumant, Zhu, Andrew X.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Preliminary Results from a Phase 1 Dose Escalation Study of FHD-286, a Novel BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, Administered As an Oral Monotherapy in Patients with Advanced Hematologic Malignancies
DiNardo, Courtney D., Savona, Michael R., Kishtagari, Ashwin, Fathi, Amir T., Bhalla, Kapil N., Agresta, Samuel, Reilly, Sarah, Almon, Caroline, Hentemann, Murphy, Hickman, Denice, Corrigan, Dillon, Macaraeg, Meghan, Piel, Jessica, Horrigan, Kim, Nabhan, Salah, Martin, Paul, Stein, Eytan M.
Published in Blood (02.11.2023)
Published in Blood (02.11.2023)
Get full text
Journal Article
Effect of itraconazole, food, and ethnic origin on the pharmacokinetics of ivosidenib in healthy subjects
Dai, David, Yang, Hua, Nabhan, Salah, Liu, Hua, Hickman, Denice, Liu, Guowen, Zacher, Jeffrey, Vutikullird, Apinya, Prakash, Chandra, Agresta, Samuel, Bowden, Chris, Fan, Bin
Published in European journal of clinical pharmacology (01.08.2019)
Published in European journal of clinical pharmacology (01.08.2019)
Get full text
Journal Article
Population Pharmacokinetics of Ivosidenib (AG-120) in Patients with IDH1-Mutant Advanced Hematologic Malignancies
Le, Kha, Wada, Russ, Dai, David, Fan, Bin, Liu, Guowen, Liu, Hua, Attar, Eyal C., Agresta, Samuel V., Yang, Hua
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: Leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma
Mahmood, S. Tariq, Agresta, Samuel, Vigil, Carlos E., Zhao, Xiuhua, Han, Gang, D'Amato, Gina, Calitri, Ciara E., Dean, Michelle, Garrett, Christopher, Schell, Michael J., Antonia, Scott, Chiappori, Alberto
Published in International journal of cancer (15.10.2011)
Published in International journal of cancer (15.10.2011)
Get full text
Journal Article
Clinical pharmacokinetics/pharmacodynamics (PK/PD) of ivosidenib in patients with IDH1-mutant advanced hematologic malignancies from a phase 1 study
Dai, David, Dinardo, Courtney Denton, Stein, Eytan, de Botton, Stéphane, Attar, Eyal C., Liu, Hua, Liu, Guowen, Lemieux, Ian, Agresta, Samuel V., Yang, Hua, Fan, Bin
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article